By conducting in vitro and in vivo functional analyses, USP13 significantly inhibited CRC angiogenesis by reducing the ubiquitination of PTEN and modulating the PTEN-AKT-VEGFA pathway. The gene discussed is VEGFA; the disease is colorectal carcinoma.